Actigraphy Device Market Insights Reveal Multi-Billion Opportunity by 2032 - Persistence Market Research

The actigraphy device market is witnessing a transformative surge, driven by increasing global healthcare concerns, especially sleep-related disorders, chronic fatigue, and lifestyle-induced health conditions. From being a specialized tool in sleep studies, these wearable and handheld devices have evolved into multi-functional tools, offering insights into human circadian rhythms, physical activity patterns, and mental health states. This expansion in usage, coupled with advancements in technology, has placed actigraphy devices at the forefront of non-invasive, long-term monitoring for both clinical and consumer applications.

According to Persistence Market Research, the global actigraphy device market size is predicted to reach US$ 11,488.2 Mn by 2032, up from US$ 2,520.0 Mn in 2025, growing at a compound annual growth rate (CAGR) of 24.2% during the forecast period from 2025 to 2032. This remarkable growth trajectory is underpinned by the widespread adoption of wearable devices, the growing demand for home-based monitoring solutions, and an increase in the recognition of actigraphy's utility beyond just sleep studies.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35405

Key Highlights from the Report

➤ The actigraphy device market is projected to grow from US$ 2,520.0 Mn in 2025 to US$ 11,488.2 Mn by 2032, with a CAGR of 24.2%.
➤ Wearable devices dominate the market, accounting for over 58.4% of the market share in 2025.
➤ Sleep disorders are anticipated to hold a 29.6% share in 2025, driven by a surge in home-based sleep monitoring solutions.
➤ North America will lead the market, contributing around 36.2% of the market share in 2025 due to high adoption rates in mental health and sleep disorder management.
➤ Pediatric and geriatric research are emerging as strong segments for actigraphy device use, fostering innovation in device functionality.
➤ The growing interest in fitness centers and sports organizations is opening new avenues for actigraphy device applications in injury recovery and athletic performance optimization.

Overview of the Market

Actigraphy devices, known for their ability to monitor rest-activity cycles, have become an indispensable tool in clinical and research settings. Initially designed to aid in sleep disorder diagnosis, these devices are now employed in numerous fields, including chronic disease management, physical activity monitoring, and mental health research. The market for these devices is growing rapidly as more healthcare professionals recognize their non-invasive, cost-effective, and long-term monitoring capabilities. Unlike conventional polysomnography, which requires a clinical setting, actigraphy devices are worn by individuals to collect data in natural environments, making them highly convenient for both patients and researchers.

Market Statistics, Growth Drivers, and Segmentation

The global actigraphy device market is expected to grow substantially over the forecast period. The increasing prevalence of sleep disorders, lifestyle-related health issues, and the desire for decentralized health monitoring systems are some of the most significant drivers behind this growth. Additionally, the adoption of wearable health technology, such as smartwatches and fitness trackers that integrate actigraphy features, has propelled the market into the consumer wellness sector.

Persistence Market Research reports that North America will lead the market, accounting for 36.2% of the total revenue share in 2025. This dominance is attributed to the strong healthcare infrastructure, increasing awareness of mental health issues, and high adoption rates of home-based monitoring solutions. The Europe market, particularly in Germany and Scandinavia, is also expected to see significant growth due to the use of actigraphy in occupational health research, while Asia Pacific, especially Japan and China, presents promising opportunities due to increasing elderly populations and rising interest in preventative healthcare.

Key Market Segmentation

Product Type: Wearable vs. Handheld

The actigraphy device market is primarily segmented into wearable and handheld devices. The wearable segment is expected to dominate the market with a projected share of 58.4% in 2025, largely due to their convenience in monitoring sleep and activity patterns over long durations. Wearables are less intrusive, enabling users to gather real-world data without the need for a clinical setting, making them especially popular for consumer health monitoring. Additionally, advancements in data analytics, AI algorithms, and sensor technology have improved the accuracy of these devices, leading to higher adoption rates among both consumers and healthcare providers.

On the other hand, handheld actigraphy devices are gaining traction in clinical settings. These devices are portable and easy to use, providing quick, reliable data for healthcare professionals. Their primary advantage lies in their ability to deliver detailed sleep-related insights in a controlled environment, making them popular for use in sleep clinics, hospitals, and research institutions.

Application Insights: Sleep Disorders, Physical Activity Monitoring, and Chronic Disease Management

In terms of application, the actigraphy device market is divided into sleep disorders, physical activity monitoring, and chronic disease management. Of these, the sleep disorders segment holds a significant share of 29.6% in 2025. The ability of actigraphy devices to monitor sleep-wake cycles non-invasively has made them indispensable for diagnosing and managing sleep disorders like insomnia, sleep apnea, and restless legs syndrome. Additionally, they provide a valuable complement to traditional sleep studies, offering objective data that can be used alongside subjective sleep logs.

The physical activity monitoring segment is also expanding rapidly, driven by the rising adoption of wearable devices to track daily activity levels, calorie burn, and general well-being. These devices are becoming increasingly important in managing chronic conditions, such as obesity and cardiovascular diseases, where activity levels play a significant role in disease progression and management.

✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/actigraphy-device-market.asp

Regional Insights

North America: The Leading Market

North America is expected to account for the largest share of the actigraphy device market, particularly in the U.S. With a significant rise in mental health disorders and sleep-related problems, the demand for non-invasive monitoring solutions like actigraphy devices has skyrocketed. This trend is supported by institutions such as the National Institutes of Health (NIH) and other sleep research centers, which increasingly use actigraphy for longitudinal studies. Furthermore, the rising trend of decentralized clinical trials and remote patient monitoring is further driving demand in the region.

Europe: Occupational Health and Regulatory Advances

In Europe, the deployment of smart actigraphy devices in occupational health research is expected to drive growth. Countries such as Germany, Sweden, and Finland are at the forefront, using actigraphy devices to study sleep disorders among shift workers, who are at a higher risk of circadian misalignment. Additionally, the European Union's Medical Device Regulation (MDR), implemented in 2021, has led to the consolidation of vendors and enhanced the quality and safety standards of actigraphy devices, making them more marketable in the region.

Asia Pacific: Elderly Health and Preventative Diagnostics

In the Asia Pacific region, Japan is poised to be a leader in adopting actigraphy devices, especially in elderly health research. The aging population in Japan has led to an increase in studies related to cognitive decline and physical activity in older adults. Additionally, China is making strides in incorporating actigraphy devices into its healthcare system, with major tech companies like Huawei and Oppo integrating actigraphy functionality into their smartwatches. The government's focus on preventive healthcare is expected to further boost the market in the region.

Market Drivers

The most significant driver for the actigraphy device market is the rising prevalence of sleep disorders globally. The increasing incidence of conditions like insomnia, sleep apnea, and restless legs syndrome has led to a demand for more accessible and non-invasive diagnostic tools. According to the National Center for Health Statistics, around 14.5% of adults in the U.S. had trouble falling asleep daily in 2020. With increasing awareness and emphasis on sleep health, actigraphy devices are becoming essential tools for both clinical diagnosis and at-home monitoring.

Market Restraints

Despite the growth prospects, actigraphy devices face certain challenges. A major limitation is their reliance on movement-based tracking, which can limit the clinical accuracy of sleep assessments. For instance, actigraphy is unable to distinguish between different stages of sleep (e.g., REM or non-REM), which can lead to misinterpretations of sleep data, especially for individuals with fragmented sleep or sleep disorders like insomnia or sleep apnea. These limitations may hinder the device's adoption in more critical clinical settings where accurate sleep staging is required.

Market Opportunities

The growing trend of personalized healthcare presents ample opportunities for actigraphy devices. With increasing demand for tailored health monitoring solutions, especially in fitness centers and sports organizations, these devices offer valuable insights into recovery, performance optimization, and injury prevention. Furthermore, the geriatric and pediatric research sectors are exploring actigraphy's potential to monitor sleep patterns and physical activity in vulnerable populations, further expanding the market potential.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35405

Reasons to Buy the Report

✔ Gain a comprehensive understanding of market trends, dynamics, and growth drivers.
✔ Analyze competitive landscapes and key players in the actigraphy device market.
✔ Identify opportunities in emerging regions such as Asia Pacific and North America.
✔ Evaluate the impact of regulatory changes and technological innovations.
✔ Forecast market growth and prepare for upcoming opportunities in health monitoring.

Company Insights
Key Players in the Actigraphy Device Market

✦ ActiGraph, LLC
✦ ActivInsights Ltd.
✦ Koninklijke Philips N.V.
✦ Fibion Inc.
✦ neurocare group AG
✦ Empatica Inc.
✦ CamNtech Ltd.
✦ Cleveland Medical Devices
✦ SOMNOmedics AG
✦ Nox Medical
✦ Fitbit
✦ CIDELEC

Recent Developments

In November 2023, ActiGraph launched the LEAP multisensor wearable, which integrates mobility, sleep, physical activity, and vital sign monitoring in one device.

In October 2023, the American Academy of Sleep Medicine introduced the Act on Actigraphy campaign, urging reimbursement for actigraphy-based sleep disorder testing.

Conclusion

The actigraphy device market is experiencing robust growth, driven by increasing awareness of sleep health, the rise in chronic health conditions, and the shift towards non-invasive, continuous monitoring solutions. As the demand for personalized healthcare solutions continues to expand, actigraphy devices-ranging from wearable devices to handheld tools-are gaining prominence across clinical, research, and consumer sectors. The market's ability to provide reliable, real-time data on sleep-wake cycles, physical activity, and circadian rhythms makes it indispensable not only for sleep disorders but also for chronic disease management and mental health studies.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.